Amoy Diagnostics Co Ltd
SZSE:300685
Amoy Diagnostics Co Ltd
SZSE:300685
Price:
20.2
CNY
-0.35%
Market Closed
Market Cap:
7.9B
CNY
Balance Sheet
Balance Sheet Decomposition
Amoy Diagnostics Co Ltd
Amoy Diagnostics Co Ltd
| Current Assets | 1.8B |
| Cash & Short-Term Investments | 1.2B |
| Receivables | 560.4m |
| Other Current Assets | 47.2m |
| Non-Current Assets | 276.4m |
| Long-Term Investments | 12m |
| PP&E | 186.3m |
| Intangibles | 43.6m |
| Other Non-Current Assets | 34.6m |
Balance Sheet
Amoy Diagnostics Co Ltd
Amoy Diagnostics Co Ltd
Currency: CNY
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
72
|
82
|
168
|
198
|
498
|
362
|
403
|
244
|
201
|
315
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
231
|
244
|
201
|
315
|
|
| Cash Equivalents |
72
|
82
|
168
|
198
|
498
|
362
|
172
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
30
|
305
|
316
|
510
|
821
|
865
|
|
| Total Receivables |
83
|
113
|
143
|
190
|
238
|
319
|
436
|
486
|
559
|
560
|
|
| Accounts Receivables |
82
|
110
|
141
|
189
|
233
|
317
|
431
|
458
|
524
|
527
|
|
| Other Receivables |
1
|
3
|
2
|
1
|
5
|
3
|
5
|
27
|
35
|
33
|
|
| Inventory |
8
|
9
|
10
|
14
|
17
|
21
|
32
|
33
|
29
|
34
|
|
| Other Current Assets |
2
|
2
|
189
|
163
|
14
|
2
|
9
|
13
|
11
|
13
|
|
| Total Current Assets |
165
|
206
|
509
|
565
|
797
|
1 009
|
1 196
|
1 285
|
1 620
|
1 788
|
|
| PP&E Net |
106
|
129
|
130
|
144
|
144
|
171
|
210
|
208
|
194
|
186
|
|
| PP&E Gross |
106
|
129
|
130
|
144
|
144
|
171
|
210
|
208
|
194
|
186
|
|
| Accumulated Depreciation |
29
|
37
|
51
|
70
|
93
|
118
|
153
|
191
|
236
|
189
|
|
| Intangible Assets |
16
|
15
|
15
|
15
|
16
|
16
|
19
|
47
|
49
|
44
|
|
| Goodwill |
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
32
|
23
|
12
|
|
| Long-Term Investments |
0
|
0
|
33
|
83
|
77
|
71
|
68
|
59
|
32
|
12
|
|
| Other Long-Term Assets |
4
|
4
|
8
|
11
|
14
|
26
|
28
|
20
|
17
|
22
|
|
| Other Assets |
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
303
N/A
|
353
+17%
|
695
+97%
|
819
+18%
|
1 047
+28%
|
1 293
+24%
|
1 520
+18%
|
1 651
+9%
|
1 935
+17%
|
2 065
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
9
|
8
|
10
|
13
|
17
|
14
|
24
|
21
|
18
|
20
|
|
| Accrued Liabilities |
11
|
13
|
17
|
24
|
28
|
39
|
57
|
53
|
70
|
64
|
|
| Short-Term Debt |
11
|
10
|
2
|
12
|
5
|
0
|
0
|
2
|
6
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
5
|
5
|
49
|
|
| Other Current Liabilities |
15
|
7
|
11
|
8
|
91
|
96
|
51
|
11
|
75
|
61
|
|
| Total Current Liabilities |
46
|
37
|
39
|
57
|
141
|
150
|
135
|
92
|
174
|
195
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
48
|
47
|
9
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Minority Interest |
7
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
|
| Other Liabilities |
9
|
9
|
7
|
5
|
4
|
15
|
11
|
10
|
11
|
18
|
|
| Total Liabilities |
62
N/A
|
45
-26%
|
46
+0%
|
62
+36%
|
145
+133%
|
164
+14%
|
155
-6%
|
151
-3%
|
232
+53%
|
222
-4%
|
|
| Equity | |||||||||||
| Common Stock |
60
|
60
|
80
|
144
|
147
|
222
|
222
|
398
|
399
|
398
|
|
| Retained Earnings |
11
|
78
|
172
|
280
|
389
|
532
|
716
|
929
|
1 136
|
1 331
|
|
| Additional Paid In Capital |
170
|
170
|
397
|
333
|
437
|
442
|
459
|
270
|
218
|
232
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
71
|
68
|
33
|
100
|
52
|
120
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Equity |
241
N/A
|
308
+28%
|
649
+111%
|
757
+17%
|
902
+19%
|
1 129
+25%
|
1 365
+21%
|
1 500
+10%
|
1 703
+14%
|
1 843
+8%
|
|
| Total Liabilities & Equity |
303
N/A
|
353
+17%
|
695
+97%
|
819
+18%
|
1 047
+28%
|
1 293
+24%
|
1 520
+18%
|
1 651
+9%
|
1 935
+17%
|
2 065
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
162
|
162
|
216
|
216
|
216
|
216
|
389
|
395
|
394
|
398
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
